Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Clinical characteristics and HLA associations of azithromycin-induced liver injury.
Aliment Pharmacol Ther
September 2024
Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Background: Azithromycin (AZ) is a widely used antibiotic. The aim of this study was to characterise the clinical features, outcomes, and HLA association in patients with drug-induced liver injury (DILI) due to AZ.
Methods: The clinical characteristics of individuals with definite, highly likely, or probable AZ-DILI enrolled in the US Drug-Induced Liver Injury Network (DILIN) were reviewed.
Azithromycin-Induced Liver Injury in Legionnaires' Disease.
Cureus
September 2021
Internal Medicine, St. Vincent Charity Medical Center, Cleveland, USA.
Drug-induced liver injury (DILI) is the leading cause of acute liver failure in the United States. Azithromycin is a commonly used antibiotic for community-acquired pneumonia that causes liver injury in rare cases. Typically, cholestatic liver injury has been reported for azithromycin, but there have only been a few case reports addressing the association with direct hepatocellular liver injury.
View Article and Find Full Text PDFAcute Hepatocellular Injury Associated With Azithromycin.
J Pharm Pract
June 2021
Department of Pharmacy Services, 22374Princeton Baptist Medical Center, Birmingham, AL, USA.
Purpose: A report of acute azithromycin-induced hepatocellular injury is described.
Summary: An 83-year-old male was admitted with possible community-acquired pneumonia and received azithromycin and ceftriaxone. After 2 doses of azithromycin, the patient's aspartate aminotransferase and alanine aminotransferase were greater than 3 times the upper limit of normal and continued to rise with subsequent doses.
Azithromycin-induced cholestatic hepatitis.
Oxf Med Case Reports
June 2017
Institute of Hepatology, Foundation for Liver Research, London, UK.
Since its introduction >20 years ago, Azithromycin has been widely used owing to its broad spectrum and good tolerability, especially when used for <7 days. In literature, there are only very few, sporadic reports available of patients developing cholestatic hepatitis following treatment with it. The current case study describes a 69-year old patient, with a medical history that included significant alcohol consumption, who presented with jaundice following a 3-day course of Azithromycin.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!